Bupivacaine liposomes for pain after lung transplant
Part of Brain & nervous system clinical trials.
This trial tests whether a special slow-release form of numbing medicine (bupivacaine liposomes) injected near the ribs can reduce pain after a double lung transplant. It aims to improve pain control and recovery after surgery.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are having a double lung transplant because of end-stage lung disease.
- You are 18 years old or older.
- Your breathing tube is expected to be removed within 48 hours after surgery.
- You do not have a body mass index (BMI) below 18 or above 35.
- You are not allergic to local anesthetics (numbing medicines).
- You are not already on a breathing machine before surgery, do not need heart-lung bypass support, and have no active infections, liver or kidney problems, bleeding issues, chronic pain, or psychiatric conditions.
- You are not pregnant or breastfeeding, and you are not having any other surgery at the same time.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial tests if a long-acting numbing medicine called liposomal bupivacaine can reduce pain after video-assisted lung surgery. It aims to help patients feel better after the procedure with less need for other painkillers.
This trial tests whether numbing medication injected around nerves in the chest can reduce pain and help patients recover faster after minimally invasive lung surgery. The goal is to improve how you feel after the procedure.
This trial tests whether a numbing medicine (liposomal bupivacaine) injected near the ribs can reduce pain after lung surgery. If you qualify, you may experience less pain and need fewer painkillers after your operation.
This trial tests a long-acting painkiller injected during surgery to see if it reduces pain after keyhole (laparoscopic) procedures like gallbladder removal, hernia repair, or appendix removal. It may help you need fewer opioids and recover more comfortably.
This trial tests whether a long-acting numbing medication (liposomal bupivacaine) injected into the abdominal wall can reduce pain after laparoscopic surgery for gynecologic cancer. If effective, it may help patients recover with less discomfort and fewer painkillers.
This trial tests a long-acting pain medication (bupivacaine liposome injection) to control pain after lung surgery done through a small cut. It may help you feel more comfortable and reduce the need for other pain medicines.
Hear when a new Lung Transplantation trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.